(Q45360818)

13 December 2017

title

Effects of antiviral therapy on long-term outcome after liver resection for hepatitis B virus-related hepatocellular carcinoma (English)

1 reference

13 December 2017

1 reference

Yorihisa Urata

1

1 reference

13 December 2017

Shoji Kubo

2

1 reference

13 December 2017

Shigekazu Takemura

3

1 reference

13 December 2017

Takahiro Uenishi

4

1 reference

13 December 2017

Shintaro Kodai

5

1 reference

13 December 2017

Hiroji Shinkawa

6

1 reference

13 December 2017

Masayuki Sakae

7

1 reference

13 December 2017

Kazuhisa Kaneda

8

1 reference

13 December 2017

Kazunori Ohata

9

1 reference

13 December 2017

Akinori Nozawa

10

1 reference

13 December 2017

Shigefumi Suehiro

11

1 reference

13 December 2017

publication date

1 November 2012

1 reference

Journal of Hepato-biliary-Pancreatic Sciences

13 December 2017

published in

1 reference

13 December 2017

volume

19

1 reference

13 December 2017

issue

6

1 reference

13 December 2017

page(s)

685-696

1 reference

Global cancer statistics, 2002

13 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00534-011-0489-Z

Hepatocellular carcinoma: diagnosis and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-011-0489-Z

Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-011-0489-Z

Prognostic determinants for chronic hepatitis B in Asians: therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-011-0489-Z

Prevention of cancer recurrence after treatment for hepatitis C virus-related hepatocellular carcinoma by interferon therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-011-0489-Z

Effect of viral status on recurrence after liver resection for patients with hepatitis B virus-related hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-011-0489-Z

Usefulness of viral concentration measurement by transcription-mediated amplification and hybridization protection as a prognostic factor for recurrence after resection of hepatitis B virus-related hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-011-0489-Z

Viral load is a significant prognostic factor for hepatitis B virus-associated hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-011-0489-Z

Recurrence of hepatitis B-related hepatocellular carcinoma is associated with high viral load at the time of resection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-011-0489-Z

High hepatitis B viral load predicts recurrence of small hepatocellular carcinoma after curative resection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-011-0489-Z

Virologic and biochemical changes and prognosis after liver resection for hepatitis B virus-related hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-011-0489-Z

Persistent hepatitis B viral replication affects recurrence of hepatocellular carcinoma after curative resection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-011-0489-Z

Histological outcome during long-term lamivudine therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-011-0489-Z

Lamivudine for patients with chronic hepatitis B and advanced liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-011-0489-Z

Efficacy of lamivudine for preventing hepatocellular carcinoma in chronic hepatitis B: A multicenter retrospective study of 2795 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-011-0489-Z

Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B for up to 5 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-011-0489-Z

Long-term entecavir therapy results in the reversal of fibrosis/cirrhosis and continued histological improvement in patients with chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-011-0489-Z

Effects of lamivudine on outcome after liver resection for hepatocellular carcinoma in patients with active replication of hepatitis B virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-011-0489-Z

Efficacy of antiviral therapy with lamivudine after initial treatment for hepatitis B virus-related hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-011-0489-Z

A comparative study of antiviral therapy after resection of hepatocellular carcinoma in the immune-active phase of hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-011-0489-Z

HBcrAg is a predictor of post-treatment recurrence of hepatocellular carcinoma during antiviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-011-0489-Z

Transection of the oesophagus for bleeding oesophageal varices

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-011-0489-Z

Incidence of hepatocellular carcinoma in chronic hepatitis B patients receiving nucleos(t)ide therapy: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-011-0489-Z

Development of HCC in patients receiving adefovir dipivoxil for lamivudine-resistant hepatitis B virus mutants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-011-0489-Z

Risk assessment for the development of hepatocellular carcinoma: according to on-treatment viral response during long-term lamivudine therapy in hepatitis B virus-related liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-011-0489-Z

Clinical significance of hepatic resection in hepatocellular carcinoma: analysis by disease-free survival curves

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-011-0489-Z

Efficacy of lamivudine therapy and factors associated with emergence of resistance in chronic hepatitis B virus infection in Japan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-011-0489-Z

Hepatitis B viral genotypes: clinical relevance and molecular characteristics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-011-0489-Z

Hepatitis B virus genotypes and virologic response in 694 patients in phase III studies of adefovir dipivoxil1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-011-0489-Z

Response to long-term lamivudine treatment in patients infected with hepatitis B virus genotypes A, B, and C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-011-0489-Z

Genotypic resistance profile of hepatitis B virus (HBV) in a large cohort of nucleos(t)ide analogue-experienced Chinese patients with chronic HBV infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00534-011-0489-Z

10.1007/S00534-011-0489-Z

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

13 December 2017

1037276942

0 references

1 reference